Versigent Affirms FY2026 Sales Guidance of $9.100B-$9.400B vs $9.286B Est
Versigent (NYSE:VGNT) affirms FY2026 sales outlook from $9.100 billion-$9.400 billion to $9.100 billion-$9.400 billion vs $9.286 billion estimate.
Versigent is sticking with its sales target for next year, but the middle of that range is a bit lower than what Wall Street was expecting. When a company keeps its forecast the same, watch whether investors think that's good enough or if they wanted to hear something bolder.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.